Ross Moat Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

KNSA Quotes by TradingView

Ross Moat is CHIEF COMMERCIAL OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 9,415 shares of KNSA, which is worth approximately $263,149. The most recent transaction as insider was on Jun 03, 2025, when has been sold 27,594 shares (Class A Ordinary Share) at a price of $29.02 per share, resulting in proceeds of $800,777. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.42K
65.98% 3M change
42.15% 12M change
Total Value Held $263,149

Ross Moat Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 03 2025
SELL
Open market or private sale
$800,777 $29.02 p/Share
27,594 Reduced 74.56%
9,415 Class A Ordinary Share
Jun 03 2025
BUY
Exercise of conversion of derivative security
$368,379 $13.35 p/Share
27,594 Added 42.71%
37,009 Class A Ordinary Share
May 05 2025
SELL
Open market or private sale
$175,616 $28.0 p/Share
6,272 Reduced 39.98%
9,415 Class A Ordinary Share
May 05 2025
BUY
Exercise of conversion of derivative security
$111,390 $17.76 p/Share
6,272 Added 28.56%
15,687 Class A Ordinary Share
May 02 2025
SELL
Open market or private sale
$107,800 $28.0 p/Share
3,850 Reduced 29.02%
9,415 Class A Ordinary Share
May 02 2025
BUY
Exercise of conversion of derivative security
$68,376 $17.76 p/Share
3,850 Added 22.49%
13,265 Class A Ordinary Share
May 01 2025
SELL
Open market or private sale
$651,016 $28.02 p/Share
23,234 Reduced 71.16%
9,415 Class A Ordinary Share
May 01 2025
BUY
Exercise of conversion of derivative security
$326,902 $14.07 p/Share
23,234 Added 41.58%
32,649 Class A Ordinary Share
Apr 29 2025
SELL
Open market or private sale
$1,614,322 $25.21 p/Share
64,035 Reduced 87.18%
9,415 Class A Ordinary Share
Apr 29 2025
BUY
Exercise of conversion of derivative security
$854,226 $13.34 p/Share
64,035 Added 46.58%
73,450 Class A Ordinary Share
Apr 21 2025
SELL
Open market or private sale
$370,475 $20.29 p/Share
18,259 Reduced 65.98%
9,415 Class A Ordinary Share
Apr 07 2025
SELL
Payment of exercise price or tax liability
$14,743 $20.28 p/Share
727 Reduced 2.56%
27,674 Class A Ordinary Share
Apr 07 2025
BUY
Exercise of conversion of derivative security
-
2,477 Added 8.02%
28,401 Class A Ordinary Share
Apr 01 2025
SELL
Payment of exercise price or tax liability
$21,421 $21.77 p/Share
984 Reduced 3.66%
25,924 Class A Ordinary Share
Apr 01 2025
BUY
Exercise of conversion of derivative security
-
3,352 Added 11.08%
26,908 Class A Ordinary Share
Mar 16 2025
SELL
Payment of exercise price or tax liability
$6,602 $22.61 p/Share
292 Reduced 1.22%
23,556 Class A Ordinary Share
Mar 16 2025
BUY
Exercise of conversion of derivative security
-
994 Added 4.0%
23,848 Class A Ordinary Share
Jan 15 2025
BUY
Grant, award, or other acquisition
$17,888 $16.0 p/Share
1,118 Added 4.66%
22,854 Class A Ordinary Share
Sep 03 2024
SELL
Open market or private sale
$1,822,944 $26.61 p/Share
68,506 Reduced 75.91%
21,736 Class A Ordinary Share
Sep 03 2024
BUY
Exercise of conversion of derivative security
$728,218 $10.63 p/Share
68,506 Added 43.15%
90,242 Class A Ordinary Share
Sep 02 2024
SELL
Payment of exercise price or tax liability
$9,225 $26.74 p/Share
345 Reduced 1.56%
21,736 Class A Ordinary Share
Sep 02 2024
BUY
Exercise of conversion of derivative security
-
994 Added 4.31%
22,081 Class A Ordinary Share
Sep 01 2024
SELL
Payment of exercise price or tax liability
$37,248 $26.74 p/Share
1,393 Reduced 6.2%
21,087 Class A Ordinary Share
Sep 01 2024
BUY
Exercise of conversion of derivative security
-
4,089 Added 15.39%
22,480 Class A Ordinary Share
Jul 15 2024
BUY
Grant, award, or other acquisition
$3,302 $15.65 p/Share
211 Added 1.13%
18,391 Class A Ordinary Share
RM

Ross Moat

CHIEF COMMERCIAL OFFICER
Hamilton, D0

Track Institutional and Insider Activities on KNSA

Follow Kiniksa Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KNSA